Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors - PubMed (original) (raw)
Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors
M A Anzano et al. Proc Natl Acad Sci U S A. 1983 Oct.
Abstract
Sarcoma growth factor (SGF) derived from conditioned medium of Moloney sarcoma virus-transformed cells and partially purified by gel filtration (crude SGF) has been characterized by its ability both to compete with epidermal growth factor (EGF) for binding to membrane receptors and to induce anchorage-independent growth of untransformed cells. We now show that further purification of crude SGF by reverse-phase HPLC on muBondapak C18 and CN columns at pH 2 resolves it into two distinctly different polypeptides, which we call types alpha and beta transforming growth factors (TGFs). Type alpha TGF (TGF-alpha), but not type beta TGF (TGF-beta), competes for binding to the EGF receptor and induces the formation of small colonies (1,000-2,000 micron2) of normal rat kidney cells in soft agar. Both TGF-beta and EGF or TGF-alpha must be present in order to induce the formation of large colonies (7,000-15,000 micron2). Based on EGF competing equivalents as determined from a radioreceptor assay with 125I-labeled EGF in normal rat kidney cells, the relative ability of EGF and TGF-alpha to potentiate TGF-beta-dependent colony formation is in the order conditioned-medium TGF-alpha greater than EGF greater than intracellular TGF-alpha. Suboptimal concentrations of the same polypeptides give additive potentiation of the TGF-beta-dependent colony-forming response; saturating levels potentiate a similar maximum response whether used alone or in various combinations. The data indicate that the EGF-competing activity of crude SGF is due to its TGF-alpha component alone, whereas the soft-agar colony-forming activity is due to the combined action of two distinct polypeptides, TGF-alpha and TGF-beta.
Similar articles
- Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS, Perroteau I, Kidwell WR, Tam J, Derynck R. Salomon DS, et al. J Cell Physiol. 1987 Mar;130(3):397-409. doi: 10.1002/jcp.1041300313. J Cell Physiol. 1987. PMID: 3494020 - Purification and properties of a type beta transforming growth factor from bovine kidney.
Roberts AB, Anzano MA, Meyers CA, Wideman J, Blacher R, Pan YC, Stein S, Lehrman SR, Smith JM, Lamb LC, et al. Roberts AB, et al. Biochemistry. 1983 Dec 6;22(25):5692-8. doi: 10.1021/bi00294a002. Biochemistry. 1983. PMID: 6607069 - Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA, Klos DJ, Grant GA. Fernandez-Pol JA, et al. Cancer Res. 1986 Oct;46(10):5153-61. Cancer Res. 1986. PMID: 3489522 - Transforming growth factor beta regulation of cell proliferation.
Moses HL, Coffey RJ Jr, Leof EB, Lyons RM, Keski-Oja J. Moses HL, et al. J Cell Physiol Suppl. 1987;Suppl 5:1-7. doi: 10.1002/jcp.1041330403. J Cell Physiol Suppl. 1987. PMID: 3316252 Review. - Regulation of cell proliferation by epidermal growth factor.
Schlessinger J, Schreiber AB, Levi A, Lax I, Libermann T, Yarden Y. Schlessinger J, et al. CRC Crit Rev Biochem. 1983;14(2):93-111. doi: 10.3109/10409238309102791. CRC Crit Rev Biochem. 1983. PMID: 6301752 Review.
Cited by
- Epithelial-mesenchymal transition stimulates human cancer cells to extend microtubule-based invasive protrusions and suppresses cell growth in collagen gel.
Oyanagi J, Ogawa T, Sato H, Higashi S, Miyazaki K. Oyanagi J, et al. PLoS One. 2012;7(12):e53209. doi: 10.1371/journal.pone.0053209. Epub 2012 Dec 31. PLoS One. 2012. PMID: 23300891 Free PMC article. - The proliferative and morphologic responses of a colon carcinoma cell line (LIM 1215) require the production of two autocrine factors.
Sizeland AM, Burgess AW. Sizeland AM, et al. Mol Cell Biol. 1991 Aug;11(8):4005-14. doi: 10.1128/mcb.11.8.4005-4014.1991. Mol Cell Biol. 1991. PMID: 2072905 Free PMC article. - Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta.
Laiho M, Saksela O, Andreasen PA, Keski-Oja J. Laiho M, et al. J Cell Biol. 1986 Dec;103(6 Pt 1):2403-10. doi: 10.1083/jcb.103.6.2403. J Cell Biol. 1986. PMID: 3491081 Free PMC article. - Transcriptional activation of the CEF-4/9E3 cytokine gene by pp60v-src.
Dehbi M, Mbiguino A, Beauchemin M, Chatelain G, Bédard PA. Dehbi M, et al. Mol Cell Biol. 1992 Apr;12(4):1490-9. doi: 10.1128/mcb.12.4.1490-1499.1992. Mol Cell Biol. 1992. PMID: 1549106 Free PMC article.
References
- Anal Biochem. 1976 May 7;72:248-54 - PubMed
- Proc Natl Acad Sci U S A. 1978 Aug;75(8):4001-5 - PubMed
- Cancer Res. 1978 Nov;38(11 Pt 2):4147-54 - PubMed
- J Cell Physiol. 1980 Feb;102(2):267-77 - PubMed
- Proc Natl Acad Sci U S A. 1980 Jun;77(6):3494-8 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous